6) Medical Countermeasures Initiative
Abstract
Integrate the regulatory science and manufacturing technologies and processes developed into the DoD MCM-ADM as enablers of the advanced development and flexible manufacturing. The MCMI budget line will transition to TM2/Bacterial Therapeutics in FY17.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2017
- Source ID
- 1191674e7d336cf20fb3538c927b8afe